Suppression of Rituximab-resistant B-cell lymphoma with a novel multi-component anti-CD20 mAb nanocluster October 4, 2015 Breakthrough Technologies Comments Off on Suppression of Rituximab-resistant B-cell lymphoma with a novel multi-component anti-CD20 mAb nanocluster Read More »
Medicine Innovates Medicine Innovates: Delivering innovations in medicine to the world for better health and prosperity
